Wolverine Trading’s Evolent Health EVH Stock Holding History

Wolverine Trading’s Portfolio EVH Stock Details EVH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-37,065	Closed	-$407K	–	5048
2024 Q4	$407K	Buy	37,065 +27,896	+304%	+$490K	﹤0.01%	3643
2024 Q3	$269K	Sell	9,169 -3,458	-27%	-$89.1K	﹤0.01%	3745
2024 Q2	$241K	Buy	+12,627	New	+$322K	﹤0.01%	3643
2022 Q2	–	Sell	-12,407	Closed	-$389K	–	4838
2022 Q1	$389K	Buy	+12,407	New	+$325K	﹤0.01%	3564
2020 Q1	–	Sell	-48,485	Closed	-$440K	–	4783
2019 Q4	$440K	Buy	48,485 +15,879	+49%	+$129K	﹤0.01%	3192
2019 Q3	$236K	Buy	32,606 +12,391	+61%	+$88.9K	﹤0.01%	3408
2019 Q2	$161K	Buy	+20,215	New	+$239K	﹤0.01%	3826
2018 Q3	–	Sell	-31,994	Closed	-$763K	–	5166
2018 Q2	$456K	Hold	31,994	–	–	﹤0.01%	3198
2018 Q1	$456K	Buy	31,994 +20,523	+179%	+$294K	﹤0.01%	3198
2017 Q4	$141K	Buy	+11,471	New	+$162K	﹤0.01%	4335
2017 Q2	–	Sell	-10,770	Closed	-$233K	–	4431
2017 Q1	$233K	Buy	+10,770	New	+$207K	﹤0.01%	3337

Other funds holding EVH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CCM

Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Wolverine Trading's EVH Position: Q1 2025 in Review

Wolverine Trading sold out of Evolent Health (EVH) in Q1 2025, closing a stake of 37,065 shares — an estimated $407K sold.

Wolverine Trading first reported a position in EVH in Q1 2017 and held it in 11 quarters. The position peaked at $456K in Q2 2018. 227 funds tracked by Wall St. Rank hold EVH as of Q1 2025.

Wolverine Trading reported no remaining Evolent Health position as of Q1 2025 after selling out during the quarter.
Wolverine Trading sold 37,065 Evolent Health shares in Q1 2025, an estimated $407K.
Wolverine Trading first reported a position in Evolent Health in Q1 2017 and held it in 11 quarters.
Wolverine Trading's Evolent Health position peaked at $456K in Q2 2018.
227 funds tracked by Wall St. Rank held Evolent Health as of Q1 2025.

Based on Wolverine Trading's 13F filing for Q1 2025, filed 15 May 2025.